4. The unprecedented reduction of LDL cholesterol
[Image from unsplash.com]
When taken with a Statin cholesterol lowering drug, the new class of drugs is expected to lower cholesterol levels by 75%.
The small interfering RNA therapy to lower LDL was also a new innovation in 2017. They are given twice a year instead of monthly or weekly like other treatments.
Dr. Leslie Cho of the Heart & Vascular Institute at the Cleveland Clinic suggests that we will continue to see a new class of agents to lower LDL levels in 2018.
Statin drugs could one day be an over-the-counter drug, said Cho.
Very promising disruptions in Healthcare. Will be interested as an incubator to closely track the development of ideas of healthcare startups.